Jushi Holdings Inc. Participates in Fireside Chat Hosted by Eight Capital – Replay Available Now
BOCA RATON, Fla., July 21, 2020 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQB: JUSHF), […]
Revival Gold Announces Increase to Previously Announced Bought Deal Financing to C$13 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, July 21, 2020 (GLOBE […]
Two LPL Financial Advisors Ranked Among Top Women Advisors in Nation
CHARLOTTE, N.C., July 21, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm, independent broker-dealer and […]
BioNTech Announces Proposed Public Offerings
MAINZ, Germany, July 21, 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the proposed public […]
Immuron Announces $20.0 Million Registered Direct Offering
MELBOURNE, Australia, July 21, 2020 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on […]
Simmons Reports Second Quarter 2020 Earnings
PINE BLUFF, Ark., July 21, 2020 (GLOBE NEWSWIRE) — Simmons First National Corporation (NASDAQ: SFNC) (the “Company” or “Simmons”) today […]
Thomas McDermott Joins EverQuote as SVP of Health & Medicare
CAMBRIDGE, Mass., July 21, 2020 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, is pleased to […]
Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19
Human dosing of LUNAR-COV19 expected soonDifferentiated STARR™ mRNA vaccine expected to produce humoral and cellular immunity at very low dosesNew […]
Greenlight Capital Re, Ltd. Announces Date of Annual Meeting of Shareholders
GRAND CAYMAN, Cayman Islands, July 21, 2020 (GLOBE NEWSWIRE) — Greenlight Capital Re, Ltd. (Nasdaq: GLRE) (“Greenlight Re” or the […]
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development […]
